OTIC 6.40 - sold the last. Just find it a bit odd that they tell shareholders in August they are cancelling a trial and then (with no update) they spring a Phase3 positive result from Europe?
Also come the Q1-filing in May their netcash should be dwindled down to about $3. Might rebuy low 4's for a flip but otherwise not interested in reentry at this time.